CN105228986A
|
|
A kind of chlorine Ka Selin eutectic and preparation method thereof, pharmaceutical composition and purposes
|
CN105229001A
|
|
The antibiotic crystal formation of Yi Zhong oxazolidinone and preparation method, composition and purposes
|
CN104955816A
|
|
Crystal form of anacetrapib and preparation method, pharmaceutical composition and use thereof
|
CN104995189A
|
|
Crystalline form of hepatitis c drug and preparation method, pharmaceutical composition and use thereof
|
CN104736538A
|
|
Inhibitor crystalline form and preparation method and use thereof
|
CN105308043A
|
|
Crystalline form of anti-hepatitis c virus drug, preparation method therefor, and pharmaceutical composition and use thereof
|
WO2015139386A1
|
|
Canagliflozin monohydrate and crystal form thereof, preparation method and use thereof
|
CN104540822A
|
|
Novel crystal form of dabrafenib mesylate and preparation method thereof
|
US2015152100A1
|
|
Solvate form M of trametinib dimethyl sulfoxide and methods of making and using thereof
|
WO2015035802A1
|
|
Vortioxetine salt and crystal thereof, their preparation method, pharmaceutical compositions and usage
|
WO2015180060A1
|
|
Salt of diazacycloheptane compound and crystal form and amorphous substance thereof
|
WO2014198178A1
|
|
Macitentan crystal, preparation method therefor, pharmaceutical composition and use thereof
|
CN104379581A
|
|
Crystal form of dabrafenib and preparation method and use thereof
|
WO2015149270A1
|
|
Crystal of trelagliptin semi-succinate and preparation method and pharmaceutical composition thereof
|
WO2015096119A1
|
|
Lorcaserin salts and crystals thereof, preparation methods and uses thereof
|
CN104918937A
|
|
Crystalline forms of trametinib and solvate thereof, preparation method therefor, pharmaceutical composition comprising same and use thereof
|
CN104884128A
|
|
Rigosertib salt, crystal form thereof, and their preparation method and application
|
WO2015035531A1
|
|
Crystal form of regorafenib salt and preparation method and application thereof
|